Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
暂无分享,去创建一个
G. Pearlson | S. Snyder | C. Tamminga | J. Links | A. Gjedde | D. Wong | A. Wilson | E. Broussolle | M. Kuhar | R. Dannals | H. Ravert | H. Wagner | L. Tune | J. K. Toung | J. Malát | J. A. Williams | L. O'Tuama | Jeffery A. Williams | Thomas J. K. Toung | S. Snyder
[1] D. Janowsky,et al. Methylphenidate, dextroamphetamine, and levamfetamine. Effects on schizophrenic symptoms. , 1976, Archives of general psychiatry.
[2] P. Seeman,et al. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains , 1978, Nature.
[3] J. Links,et al. Dopamine receptor binding of C-11-3-N-methylspiperone in the caudate in schizophrenia and bipolar disorder: a preliminary report. , 1985, Psychopharmacology bulletin.
[4] D Hommer,et al. Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled series. , 1985, Archives of general psychiatry.
[5] H. Lôo,et al. Brain distribution and kinetics of 11C-chlorpromazine in schizophrenics: Positron emission tomography studies , 1979, Psychiatry Research.
[6] T. Crow,et al. CEREBRAL VENTRICULAR SIZE AND COGNITIVE IMPAIRMENT IN CHRONIC SCHIZOPHRENIA , 1976, The Lancet.
[7] D. Bell,et al. Comparison of Amphetamine Psychosis and Schizophrenia , 1965, British Journal of Psychiatry.
[8] N C Andreasen,et al. Negative v positive schizophrenia. Definition and validation. , 1982, Archives of general psychiatry.
[9] J S Fowler,et al. [18F]-N-Methylspiroperidol: the radioligand of choice for PETT studies of the dopamine receptor in human brain. , 1985, Life sciences.
[10] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[11] P. Seeman,et al. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. , 1977, Life sciences.
[12] S. R. Hirsch,et al. 15O POSITRON EMISSION TOMOGRAPHIC SCANNING IN PREDOMINANTLY NEVER-TREATED ACUTE SCHIZOPHRENIC PATIENTS , 1983, The Lancet.
[13] M. Folstein,et al. EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN , 1984, Science.
[14] R. Naquet,et al. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors. , 1984, Life sciences.
[15] O. DeJesus,et al. In vivo binding of spiroperidol and bromospiroperidol at low drug loadings. , 1984, Life sciences.
[16] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[17] Jonathan M. Links,et al. Imaging dopamine receptors in the human brain by positron tomography , 1983 .
[18] R. Hichwa,et al. Human brain receptor distribution. , 1986, Science.
[19] T. Crow,et al. Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration. , 1979, Life Science.
[20] P Riederer,et al. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. , 1984, Science.
[21] L L Iversen,et al. Increased brain dopamine and dopamine receptors in schizophrenia. , 1982, Archives of general psychiatry.
[22] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[23] P. Greengard,et al. Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. D. Arnett,et al. Comparison of Three 18F‐Labeled Butyrophenone Neuroleptic Drugs in the Baboon Using Positron Emission Tomography , 1985, Journal of neurochemistry.
[25] S. Snyder,et al. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines. , 1973, The American journal of psychiatry.
[26] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[27] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[28] M. Poulter,et al. INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA , 1978, The Lancet.
[29] D. Weinberger,et al. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.
[30] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.